Johnson & Johnson spent a whopping $7.55 billion, coming in second behind eye care-developer Alcon, which spent more than $9.5 billion. Meanwhile, Medtronic spent a reported $1.5 billion.
The average amount spent on research and development projects last year was $540 million.
More Articles on Orthopedic Devices:
Conmed’s Arthroscopic Business Line Sees 15% Growth
CareFusion Reports $968M 4Q Revenue, Up 3%
8 Spine Device Company 2Q Financial Reports
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.